Effects of cyclosporin, phenytoin, and nifedipine on the synthesis and degradation of gingival collagen in tufted capuchin monkeys (cebus apella): Histochemical and mmp-1 and -2 and collagen i gene expression analyses

Journal of Periodontology

Volumn 79, Issue 1, 2008, Pages 114-122

  Kanno, Claudia M ^a   Oliveira, José A ^a   Garcia, José F ^a   Castro, Alvimar L ^a   Crivelini, Marcelo M ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Collagen type i; Cyclosporin; Gingival overgrowth chemically induced; Matrix metalloproteinase; Nifedipine; Phenytoin

Indexed keywords

ANTICONVULSIVE AGENT; AZO COMPOUND; C.I. DIRECT RED 80; CALCIUM CHANNEL BLOCKING AGENT; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; COLORING AGENT; CYCLOSPORIN; DIAGNOSTIC AGENT; ENZYME INHIBITOR; GELATINASE A; INTERSTITIAL COLLAGENASE; NIFEDIPINE; PHENYTOIN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOPSY; CEBIDAE; CHEMICALLY INDUCED DISORDER; CYTOCHEMISTRY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GINGIVA; GINGIVA OVERGROWTH; GINGIVITIS; MALE; PATHOLOGY; RANDOMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTICONVULSANTS; AZO COMPOUNDS; BIOPSY; CALCIUM CHANNEL BLOCKERS; CEBUS; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE IV; COLORING AGENTS; CYCLOSPORINE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GINGIVA; GINGIVAL OVERGROWTH; GINGIVITIS; HISTOCYTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; NIFEDIPINE; PHENYTOIN; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 38549169653     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070267     Document Type: Article

References (37)

1. Neville BW, Damm DD, Allen CM, Bouquot JE. Oral and Maxillofacial Pathology. Philadelphia: W.B. Saunders; 1995:129-132.
2. Kataoka M, Shimizu Y, Kunikiyo K, et al. Nifedipine induces gingival overgrowth in rats through a reduction in collagen phagocytosis by gingival fibroblasts. J Periodontol 2001;72:1078-1083.
3. McKevitt KMB, Irwin CR. Phenotypic differences in growth, matrix synthesis and response to nifedipine between fibroblasts derived from clinically healthy and overgrown gingival tissue. J Oral Pathol Med 1995;24: 66-71.
4. Mariotti A, Hassell T, Jacobs D, Manning CJ, Hefti AF. Cyclosporin A and hydroxycyclosporine (M-17) affect the secretory phenotype of human gingival fibroblasts. J Oral Pathol Med 1998;27:260-266.
5. Kato T, Okahashi N, Kawai S, et al. Impaired degradation of matrix collagen in human gingival fibroblasts by the antiepileptic drug phenytoin. J Periodontol 2005;76:941-950.
6. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64: 474-484.
7. Montes GS, Junqueira LC. The use of the picrosiriuspolarization method for the study of the biopathology of collagen. Mem Inst Oswaldo Cruz 1991;86:1-11.
8. Hyland PL, Traynor PS, Myrillas TT, et al. The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts. J Periodontol 2003;74:437-445.
9. Zebrowski EJ, Pylypas SP, Odlum O, Johnson RB. Comparative metabolism by fibroblast populations exposed to cyclosporine. J Periodontol 1994;65:565-567.
10. Iacopino AM, Doxey D, Cutler CW, et al. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: Possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol 1997;68:73-83.
11. Pernu HE, Knuuttila MLE. Macrophages and lymphocyte subpopulations in nifedipine- and cyclosporin A-associated human gingival overgrowth. J Periodontol 2001;72:160-166.
12. Nares S, Ng MC, Dill RE, Park B, Cutler CW, Iacopino AM. Cyclosporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva. J Periodontol 1996;67:271-278.
13. Plemons JM, Dill RE, Rees TD, Dyer BJ, Ng MC, Iacopino AM. PDGF-B producing cells and PDGF-B gene expression in normal gingival and cyclosporine A-induced gingival overgrowth. J Periodontol 1996; 67:264-270.
14. Nurmenniemi PK, Pernu HE, Laukkanen P, Knuuttila MLE. Macrophage subpopulations in gingival overgrowth induced by nifedipine and immunosuppressive medication. J Periodontol 2002;73:1323-1330.
15. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995;7:728-735.
16. Mühlemann HR, Son S. Gingival sulcus bleeding - A leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107-113.
17. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21: 533-551.
18. Gilmore RM. Mammalogy in an epidemiological study of jungle yellow fever in Brazil. J Mammal 1943;24: 144-162.
19. Junqueira LCU, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979;11:447-455.
20. Marshall RI, Bartold PM. A clinical review of drug-induced gingival overgrowths. Aust Dent J 1999;44: 219-232.
21. Thomason JM, Sloan P, Seymour RA. Immunolocalization of collagenase (MMP-1) and stromelysin, (MMP-3) in the gingival tissues of organ transplant patients medicated with cyclosporin. J Clin Periodontol 1998;25: 554-560.
22. McGaw WT, Porter H. Cyclosporine-induced gingival overgrowth: An ultrastructural stereologic study. Oral Surg Oral Med Oral Pathol 1988;65:186-190.
23. Daley TD, Wysocki GP, Day C. Clinical and pharmacologie correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986;62: 417-421.
24. Rich L, Whittaker P. Collagen and picrosirius red staining: A polarized light assessment of fibrilla hue and spatial distribution. Braz J Morphol Sci 2005;22:97-104.
25. Dayan D, Hiss Y, Hirshberg A, Bubis JJ, Wolman M. Are the polarization colors of picrosirius red-stained collagen determined only by the diameter of the fibers? Histochemistry 1989;93:27-29.
26. Sculean A, Junker R, Donos N, Berakdar M, Brecx M, Dünker N. Immunohistochemical evaluation of matrix molecules associated with wound healing following regenerative periodontal treatment in monkeys. Clin Oral Investig 2002;6:175-182.
27. Werfully S, Areibi Q, Toner M, et al. Tensile strength, histological and immunohistochemical observations of periodontal wound healing in the dog. J Periodontal Res 2002;37:366-374.
28. Meikle MC, Hembry RM, Holley J, Horton C, McFarlane CG, Reynolds JJ. Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients. J Periodontal Res 1994;29:118-126.
29. Uzel MI, Kantarci A, Hong H-H, et al. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol 2001;72:921-931.
30. Romanos GE, Strub JR, Bernimoulin J-P. Immunohistochemical distribution of extracellular matrix proteins as a diagnostic parameter in healthy and diseased gingiva. J Periodontol 1993;64:110-119.
31. James JA, Irwin CR, Linden GJ. Gingival fibroblast response to cyclosporin A and transforming growth factor β1. J Periodontal Res 1998;33:40-48.
32. Woolley DE, Davies RM. Immunolocalization of collagenase in periodontal disease. J Periodontal Res 1981; 16:292-297.
33. Romanelli R, Romanelli R, Mancini S, et al. Activation of neutrophil collagenase in periodontitis. Infect Immun 1999;67:2319-2326.
34. Kubota T, Nomura T, Takahashi T, Hara K. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue. Arch. Oral Biol 1996; 41:253-262.
35. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of the Cell, 4th ed. New York: Garland Publishing; 2002:1065-1126.
36. Hassell TM, Roebuck S, Page RC, Wray SH. Quantitative histopathologic assessment of developing phenytoin-induced gingival overgrowth in the cat. J Clin Periodontol 1982;9:365-372.
37. Spolidorio LC, Spolidorio DM, Holzhausen M. Effects of long-term cyclosporin therapy on the periodontium of rats. J Periodontal Res 2004;39:257-262.